Delivery Order SPE2DB20D3101-SPE2DB23FRWP0
- Not listed
- This federal contract award, valued at $2,078.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Synthroid 88 MCG tablets in quantities of 1,000. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order, valued at $7,120.16, is for the provision of Synthroid 88 MCG tablets. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,958.96 firm fixed-price delivery order is for 4,567,034,802 units of Synthroid 88 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,091.35 firm fixed-price delivery order is for the supply of Synthroid 100 mcg tablets in 1,000-count containers. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,571.54, is for the delivery of Synthroid 88 MCG tablets. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $7,421.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Synthroid 137 MCG Tablets in 1,000-count containers. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Synthroid 25 MCG tablets in 1,000 count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. This is a firm fixed-price delivery order contract with a ceiling value of $1,462.38 and a completion date of May 14, 2024. The contract is not a set-aside award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,142.08 firm fixed-price delivery order is for the supply of Synthroid 88 MCG tablets in quantities of 1,000. The award has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,957.00, is a Firm Fixed Price Delivery Order for the supply of SYNTHROID 88 MCG TABLET 1000S. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. The place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 1,000 units of Synthroid 25 mcg tablets. The $2,729 firm fixed-price delivery order has an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRWP0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $28,755.30 contract is for the delivery of Synthroid 88 MCG Tablets in quantities of 1,000, with a period of performance through September 6, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous contracts with the DLA and other federal agencies to supply a wide range of essential medical products, including specialty medications, generic drugs, and medical devices. The company holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.8k | 9/5/23 |